OBIO
Orchestra BioMed Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.00
+7.91%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$6.03
From 52W high−5.51%
Volume335412.00
Market cap$360.63M
P/E (TTM)—
P/S (TTM)11.3x
Div yield—
Key dataNov 4, 2026
Open
$6.03
From 52W high
−5.51%
Volume
335412.00
Market cap
$360.63M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−5.8x
P/E (TTM)
—
RSI (14)
54.9
MomentumView details →
1D Return
+7.91%
YTD Return
+44.34%
SummaryUpdated Jun 1, 2026
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) is a biomedical innovation company founded in 2020 and based in New Hope, Pennsylvania. The company went public on August 4, 2020, and operates as a development-stage biotechnology firm focused on creating medical devices and therapies for cardiovascular and other critical health conditions. Orchestra BioMed has established strategic partnerships with major medical device companies including Medtronic and Terumo Corporation to advance its product pipeline through clinical development and eventual commercialization.
Similar companies
Latest newsMore news →
Orchestra BioMed Holdings, Inc. (OBIO) shares jumped 5.2% in the previous session on above-average trading volume.44d agoOrchestra BioMed announced that its investigational AVIM Therapy will be featured in two sessions at HRX Live 2026, the Heart Rhythm Society's annual meeting in Atlanta, Georgia on September 18-20, 2026.49d ago